Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | OMER | Common Stock | Options Exercise | $151K | +36.9K | +1.82% | $4.10 | 2.06M | Jun 15, 2021 | Direct | |
transaction | OMER | Common Stock | Sale | -$554K | -36.9K | -1.79% | $15.02 | 2.03M | Jun 15, 2021 | Direct | F1, F2 |
transaction | OMER | Common Stock | Options Exercise | $151K | +36.9K | +1.82% | $4.10 | 2.06M | Jun 17, 2021 | Direct | |
transaction | OMER | Common Stock | Sale | -$549K | -36.9K | -1.79% | $14.90 | 2.03M | Jun 17, 2021 | Direct | F1, F3 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | OMER | Stock Option (right to buy) | Options Exercise | $0 | -36.9K | -50% | $0.00 | 36.9K | Jun 15, 2021 | Common Stock | 36.9K | $4.10 | Direct | F4 |
transaction | OMER | Stock Option (right to buy) | Options Exercise | $0 | -36.9K | -100% | $0.00* | 0 | Jun 17, 2021 | Common Stock | 36.9K | $4.10 | Direct | F4 |
Id | Content |
---|---|
F1 | Open market sale pursuant to a previously established Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2020 for expiring options. The trading schedule, including sale dates and the number of shares to be sold, was established at the time of the trading plan's adoption in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. |
F2 | This transaction was executed in multiple trades at prices ranging from $14.83 to $15.45; the price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. |
F3 | This transaction was executed in multiple trades at prices ranging from $14.72 to $15.06; the price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. |
F4 | The shares subject to this option vested and became exercisable over 48 monthly installments, with a vesting commencement date of April 1, 2011. |